InnoCore receives GMP Certificate
Groningen, March 7, 2013: InnoCore Pharmaceuticals is proud to announce it has qualified for GMP certification by the Dutch Government.
On 29th of January 2013, InnoCore has been inspected by the Dutch Health Care Inspectorate, the competent authority of The Netherlands. The conclusion of this thorough inspection was, that InnoCore ‘complies with the principles and guidelines of Good Manufacturing Practice laid down in Directive 2003/94/EC.’ As a result, a certificate of GMP compliance was issued to InnoCore by the Dutch Health Care Inspectorate.
“ This is the official reward from the Dutch government to our team for all the hard work we did to bring our quality documentation and procedures up to the level required by our international pharmaceutical partners and by competent authorities all over the world”, Jan Hendriks, CEO of InnoCore comments. “This is definitely an important milestone for InnoCore and it shows we are right on track with our plans on manufacturing Clinical Trial Materials soon with the sophisticated Polymeric Drug Delivery Systems we develop”
About InnoCore: InnoCore is specialized in the development of polymer-based controlled release depots for pharmaceuticals. InnoCore's technologies are covered by a strong IP portfolio and the company operates with a highly skilled multidisciplinary team of scientists and technicians. InnoCore Pharmaceuticals is a privately held company founded in 2004 and located in The Netherlands.
For further information, please contact us:
Phone: +31 (0)50 575 3100 / Email: firstname.lastname@example.orgGo back to News